Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001615774-18-010709
Filing Date
2018-10-11
Accepted
2018-10-11 07:42:08
Documents
11
Period of Report
2018-10-10

Document Format Files

Seq Description Document Type Size
1 6-K s113237_6k.htm 6-K 19317
2 EXHIBIT 99.1 s113237_ex99-1.htm EX-99.1 328928
3 EXHIBIT 99.2 s113237_ex99-2.htm EX-99.2 69612
4 GRAPHIC img007_v1.jpg GRAPHIC 2564
5 GRAPHIC img001_v1.jpg GRAPHIC 43416
6 GRAPHIC img002_v1.jpg GRAPHIC 9696
7 GRAPHIC img003_v1.jpg GRAPHIC 1835
8 GRAPHIC img006_v1.jpg GRAPHIC 3358
9 GRAPHIC img003a_v1.jpg GRAPHIC 3718
10 GRAPHIC img004_v1.jpg GRAPHIC 2353
11 GRAPHIC img005_v1.jpg GRAPHIC 1616
  Complete submission text file 0001615774-18-010709.txt   514326
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 181117279
SIC: 2834 Pharmaceutical Preparations